Clinical Textbook of Addictive Disorders 3rd ed - R. Frances, S. Miller, A. Mack (Guilford, 2005) WW

Index 665dietary guidelines, 75–76endocrine dysfunction related to, 95epidemic abuse, 20, 27fetal alcohol syndrome, 97, 441flushing reaction, 19, 330gastrointestinal complications relatedto, 90–91gateway theory of adolescentsubstance abuse, 560–561, 563gender differences, 439–449genetic factors, 442, 537health effects, 440hematologic complications related to,94–95HIV infection risk and, 415–416,417–418immune function and, 95, 417–418intoxication, 86laboratory testing, 65, 77–78liver complications related to, 91–92musculoskeletal problems related to,95neurobiological effects, 7, 11, 93–94patterns of, 20, 45–47, 75, 76, 78pharmacology, 84–86polydrug abuse, 248, 249, 250, 251,258–259racial/ethnic differences, 82–84, 322,323–324, 329, 330–331, 332–333religious beliefs and attitudes and,330sexual behavior and, 441sexual dysfunction related to, 89–90skin problems related to, 96sleep disturbances associated with, 89social costs, 75treatment. See Alcohol abusetreatmentvehicle operations and, 351, 358violent behavior and, 356–357vitamin deficiencies related to, 88, 90,91, 92withdrawal, 86–87in workplace, 341Alcohol Use Inventory, 46Aldehyde dehydrogenase, 84Alexithymia, 461, 467Alprazolam, 225, 228, 229tine-release formulations, 237withdrawal, 231Americans with Disabilities Act, 341Amitryptyline, 225Amnestic disorder, alcohol-induced, 87–88Amobarbital, 113, 224Amphetaminesadolescent use patterns, 560comorbid alcohol abuse, 79laboratory testing for, 65Anemia, alcohol-induced, 94Antidepressant therapy, 238with ADHD patient, 289cocaine addiction treatment, 202with dually diagnosed patients, 286with elderly patients, 404–405heroin overdose risk and, 260for pathological gambling, 309for smoking cessation, 590–591See also specific drug; specific drug typeAntihistamines, 225Antisocial personality disorder, 11, 357alcohol abuse and, 82comorbid substance use disorder, 253,254, 272, 273Anxiety disordersin addicted persons, 230–231in adolescents, 567alcohol use and, 80, 89, 98benzodiazepine discontinuation inpeople with, 236–237benzodiazepine therapy, 221, 230–231comorbid substance use disorder, 273co-occurring kleptomania, 314co-occurring pathological gambling,308epidemiology, 220gender differences, 253pharmacotherapy with duallydiagnosed patients, 288–289social costs, 220Asian Americansalcohol use and abuse, 83–84, 330–331population statistics, 321, 330